Wong Alan, Dunn Charles
Kansas City University and Advent Health Orlando
Kansas City University
The key advantages of Mohs micrographic surgery (MMS) include precise microscopic control of tumor margins through specialized tissue processing techniques and the conservation of healthy tissue. Please see StatPearls' companion resource, "Mohs Micrographic Surgery," for more information. A complete margin assessment requires high-quality frozen sections free from processing errors that could impede the surgeon's ability to accurately examine the tumor. Inadequate techniques may result in improper staining, misorientation of margins, misinterpretation of tumor margins, and loss of critical tumor characteristics. Ultimately, these issues can lead to patient harm, suboptimal postoperative management, increased risk of disease recurrence, and higher costs. The technique for creating frozen sections and staining (including immunostaining) in MMS is similar to other forms of pathological sectioning and staining. However, Mohs surgeons and histology technicians use various methods for processing. The tissue is prepared to allow for the assessment of 100% of the peripheral and deep margins in a single section. This is accomplished by manipulating the excised specimen to ensure that the peripheral and deep margins lie in the same plane, mounting the specimen on a chuck for sectioning, and using a cryostat to freeze the tissue and cut frozen sections with a microtome blade. Staining is performed after the specimen is cut on the microtome and transferred to a glass slide. Hematoxylin and eosin (H&E) staining is the most commonly used method in MMS. Toluidine blue is used less frequently and is primarily applied when treating basal cell carcinomas (BCCs). Immunohistochemistry is mainly utilized for melanomas, with the melanoma antigen recognized by T cells (MART-1) stain being the most common in MMS. Other immunohistochemistry stains for melanoma include SOX10, PRAME, HMB-45, MEL-5, and S100. While immunostaining with cytokeratins can be helpful for detecting BCCs and squamous cell carcinomas (SCCs), few surgeons use this method due to the increased time and cost involved. Reports have indicated that cytokeratin stains can be useful for confirming perineural invasion in SCCs and BCCs. When interpreting slides, surgeons should note any changes in slide quality resulting from processing errors and devise strategies to address these issues. This plan must be communicated to the entire team, particularly the histology technicians. Common findings associated with processing errors include tears or holes in tissue sections, excessive or minimal staining, bubbles, and water beads. Prompt recognition of these issues is crucial, as it enables the team to identify the most appropriate troubleshooting techniques to resolve the processing errors.
莫氏显微外科手术(MMS)的主要优势包括通过专门的组织处理技术对肿瘤边缘进行精确的显微镜控制以及对健康组织的保留。更多信息请参阅StatPearls的配套资源“莫氏显微外科手术”。完整的边缘评估需要高质量的冷冻切片,且不存在可能妨碍外科医生准确检查肿瘤的处理错误。技术不完善可能导致染色不当、边缘方向错误、肿瘤边缘误判以及关键肿瘤特征丧失。最终,这些问题可能导致患者受到伤害、术后管理不理想、疾病复发风险增加以及成本上升。MMS中制作冷冻切片和染色(包括免疫染色)的技术与其他形式的病理切片和染色相似。然而,莫氏外科医生和组织学技术人员使用各种处理方法。组织的制备应能在单个切片中评估100%的周边和深部边缘。这通过操作切除的标本以确保周边和深部边缘位于同一平面、将标本安装在切片夹上进行切片以及使用低温恒温器冷冻组织并用切片机刀片切割冷冻切片来实现。在标本用切片机切割并转移到载玻片后进行染色。苏木精和伊红(H&E)染色是MMS中最常用的方法。甲苯胺蓝使用频率较低,主要用于治疗基底细胞癌(BCC)时。免疫组织化学主要用于黑色素瘤,其中T细胞识别的黑色素瘤抗原(MART-1)染色是MMS中最常见的。黑色素瘤的其他免疫组织化学染色包括SOX10、PRAME、HMB-45、MEL-5和S100。虽然细胞角蛋白免疫染色有助于检测BCC和鳞状细胞癌(SCC),但由于时间和成本增加,很少有外科医生使用这种方法。报告表明,细胞角蛋白染色可用于确认SCC和BCC中的神经周围浸润。在解读玻片时,外科医生应注意处理错误导致的玻片质量变化,并制定解决这些问题的策略。该计划必须传达给整个团队,特别是组织学技术人员。与处理错误相关的常见发现包括组织切片中的撕裂或孔洞、染色过度或不足、气泡和水珠。及时识别这些问题至关重要,因为这使团队能够确定最合适的故障排除技术来解决处理错误。